Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial
Background: Few studies have examined the effect of seborrheic dermatitis (SD) and/or its consequent therapy on a patient’s quality of life. Itraconazole has been suggested as an effective therapy for severe SD but its impact on Quality of Life (QoL) in these patients has never been studied before....
Saved in:
Main Authors: | Zaheer Abbas, Seyede Zahra Ghodsi, Robabeh Abedeni |
---|---|
Format: | article |
Language: | EN |
Published: |
Mattioli1885
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/7904c2cf8fa04a7fb3710ba2a1d06b3a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Staphylococcus aureus is the most common bacterial agent of the skin flora of patients with seborrheic dermatitis
by: Funda Tamer, et al.
Published: (2018) -
Clonal Seborrheic Keratosis: A Diagnostic Dilemma
by: Satish Udare, et al.
Published: (2021) -
When Seborrheic Keratosis Is Wearing a Mask
by: Cristina Sousa, et al.
Published: (2020) -
Polymorphic Vessels—Think About Seborrheic Keratosis
by: Teresa Deinlein, et al.
Published: (2020) -
Association between melanocytic neoplasms and seborrheic keratosis: more than a coincidental collision?
by: Jennifer DeFazio, et al.
Published: (2012)